Prescribing in COVID-19 patients: Should we take into account inflammation?
Détails
ID Serval
serval:BIB_828321D63244
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Editorial
Collection
Publications
Institution
Titre
Prescribing in COVID-19 patients: Should we take into account inflammation?
Périodique
Br J Clin Pharmacol
ISSN
1365-2125 (Electronic)
ISSN-L
0306-5251
Statut éditorial
Publié
Date de publication
03/2021
Peer-reviewed
Oui
Volume
87
Numéro
3
Pages
719-721
Langue
anglais
Notes
Marzolini, Catia
Battegay, Manuel
Sendi, Parham
Back, David J
eng
Adolf and Mary Mil foundation/
Research Support, Non-U.S. Gov't
Review
England
Br J Clin Pharmacol. 2021 Mar;87(3):719-721. doi: 10.1111/bcp.14524. Epub 2020 Aug 20.
Battegay, Manuel
Sendi, Parham
Back, David J
eng
Adolf and Mary Mil foundation/
Research Support, Non-U.S. Gov't
Review
England
Br J Clin Pharmacol. 2021 Mar;87(3):719-721. doi: 10.1111/bcp.14524. Epub 2020 Aug 20.
Mots-clé
Anti-Inflammatory Agents/*therapeutic use, Antiviral Agents/therapeutic use, COVID-19/*complications, *Drug Prescriptions, Drug Therapy, Combination, Humans, Inflammation/*drug therapy/*etiology, *COVID-19 Drug Treatment, Covid-19, drug-drug interactions, inflammation, inhibition drug metabolism
Pubmed
Création de la notice
25/08/2023 6:17
Dernière modification de la notice
27/08/2023 7:01
Données d'usage
